Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats
- PMID: 15569874
- DOI: 10.1161/01.STR.0000149624.87661.18
Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats
Abstract
Background and purpose: Insulin-like growth factor-1 (IGF-1) and caffeinol are both neuroprotective and probably have different mechanisms of action; therefore, they may be more effective in combination.
Methods: We tested the N-terminal tripeptide of IGF-1, Gly-Pro-Glu (GPE), and its analogue, G2MePE, alone and with caffeinol in a rat middle cerebral artery (MCA) suture occlusion model. We randomly assigned rats to 6 groups of 8 to 12 animals: (1) control; (2) GPE, 3 mg/kg per hour; (3) G2MePE, 0.3 mg/kg per hour; (4) caffeinol, a mixture of caffeine (10 mg/kg) with ethanol (0.32 g/kg); (5) GPE with caffeinol (combination of group 2 with 4); and (6) G2MePE with caffeinol (combination of group 3 with 4). Drugs were started 75 minutes after suture occlusion, at the start of reperfusion. Three days after MCA occlusion, neurological deficit (Neurological Deficit Score [NDS]) and lesion volume were measured.
Results: GPE and caffeinol improved NDS by 34% and 36%, respectively (P<0.01), and also decreased cortical but not striatal lesion volume compared with control (GPE cortex, 121 mm3; caffeinol cortex, 134 mm3; and control, 221 mm3; P<0.01). GPE plus caffeinol did not have more efficacy than either GPE or caffeinol alone. G2MePE slightly improved NDS (19.7%, P=0.05) but not lesion volume. However, G2MePE plus caffeinol very significantly improved NDS (64%) and lesion volume in both cortex (combination 95 mm3 versus control 221 mm3) and striatum (combination 74 mm3 versus control 110 mm3) (P<0.001), and was significantly more effective than either caffeinol or G2MePE alone.
Conclusions: Both GPE and caffeinol significantly protect cortex after MCA occlusion. At the doses used in this study, the GPE analogue G2MePE by itself had minimal protective effects, but when combined with caffeinol, it demonstrated robust beneficial effects on cortical and subcortical lesion size and behavioral deficit. Further study of this combination appears justified.
Similar articles
-
Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.Stroke. 2003 May;34(5):1246-51. doi: 10.1161/01.STR.0000068170.80517.B3. Epub 2003 Apr 10. Stroke. 2003. PMID: 12690223
-
Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.Stroke. 2003 May;34(5):1242-5. doi: 10.1161/01.STR.0000067706.23777.04. Epub 2003 Apr 10. Stroke. 2003. PMID: 12690224 Clinical Trial.
-
Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats.Brain Res. 2004 May 22;1008(2):278-83. doi: 10.1016/j.brainres.2004.02.039. Brain Res. 2004. PMID: 15145766
-
[Caffeinol: a neuroprotective action in ischemic brain damage].Przegl Lek. 2015;72(11):677-81. Przegl Lek. 2015. PMID: 27012130 Review. Polish.
-
IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.Br J Pharmacol. 2009 Jul;157(6):881-91. doi: 10.1111/j.1476-5381.2009.00256.x. Epub 2009 May 11. Br J Pharmacol. 2009. PMID: 19438508 Free PMC article. Review.
Cited by
-
Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine.Stroke. 2010 Feb;41(2):363-7. doi: 10.1161/STROKEAHA.109.562900. Epub 2009 Dec 31. Stroke. 2010. PMID: 20044532 Free PMC article.
-
Treatment of acute cerebral ischemia using animal models: a meta-analysis.Transl Neurosci. 2015 Feb 11;6(1):47-58. doi: 10.1515/tnsci-2015-0006. eCollection 2015. Transl Neurosci. 2015. PMID: 28123790 Free PMC article. Review.
-
Mucosal tolerance to E-selectin and response to systemic inflammation.J Cereb Blood Flow Metab. 2006 Dec;26(12):1538-50. doi: 10.1038/sj.jcbfm.9600308. Epub 2006 Apr 5. J Cereb Blood Flow Metab. 2006. PMID: 16596122 Free PMC article.
-
Growth factors and stroke.NeuroRx. 2006 Oct;3(4):458-65. doi: 10.1016/j.nurx.2006.08.003. NeuroRx. 2006. PMID: 17012059 Free PMC article. Review.
-
Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury.CNS Neurosci Ther. 2011 Aug;17(4):250-5. doi: 10.1111/j.1755-5949.2009.00128.x. Epub 2010 Mar 4. CNS Neurosci Ther. 2011. PMID: 20236140 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous